Dovonex Related Published Studies
Well-designed clinical trials related to Dovonex (Calcipotriene Topical)
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. [2008.09]
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. [2006.10]
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. [2003.01]
A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis. [2000.10]
Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks. [2000.07]
Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. [1998.09]
Evaluating the safety of calcipotriene 30 g per day in patients with psoriasis: a parallel group, vehicle-controlled study. [1998.04]
Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions. [1998.01]
Topical calcipotriene in combination with UVB phototherapy for psoriasis. [1997.04]
Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis. [1996.03]
Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group. [1995.01]
Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis. [1994.11]
Well-designed clinical trials possibly related to Dovonex (Calcipotriene Topical)
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. [2008.04]
Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure. [2008.02]
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting. [2008.02]
Smoothing the mosaic subclinical melanoderma by calcipotriol. [2007.05]
Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. [2007.04]
An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. [2007.04]
A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation. [2007.01]
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet((R))) versus calcipotriol (Daivonex((R))) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial. [2007]
Effect of topical vitamin D analogue on in vivo contact sensitization. [2006.10]
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. [2006.10]
1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. [2006.09]
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment. [2006.08]
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. [2006.06]
Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. [2006.05]
The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis. [2006.05]
Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. [2006.03]
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. [2006]
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris. [2006]
'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. [2005.07]
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. [2005.02]
Efficacy and local safety of a calcipotriol/ betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris. [2005.01]
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris. [2005]
Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis. [2005]
Psoriasis vulgaris: once-versus twice-daily application of calcipotriol cream. [2005]
Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis. [2005]
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. [2004.09]
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. [2004.06]
A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus. [2004.06]
A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris. [2004.04]
Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol. [2004.03]
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. [2004]
Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis. [2003.10]
Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis. [2003.08]
Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis. [2003.07]
Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. [2003.07]
Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis. [2003.05]
Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. [2003.02]
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial. [2003.02]
Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. [2003.01]
Scalp psoriasis: synergy between the Malassezia yeasts and skin irritation due to calcipotriol. [2003]
The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment. [2003]
The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy. [2003]
Vitamin D and psoralen plus UVA radiation. [2002.11]
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. [2002.08]
Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis. [2002.07]
Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients. [2002.06]
Instrumental evaluation of retinoid-induced skin irritation. [2002.05]
Topical preparations for the treatment of psoriasis: a systematic review. [2002.03]
A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. [2002]
Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. [2002]
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. [2002]
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis. [2002]
Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. [2001.09]
Comparison of calcipotriol and coal tar in conjunction with sun exposure in chronic plaque psoriasis: a pilot study. [2001.08]
The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. [2001.05]
Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study. [2001]
Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. [2001]
Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis. [2001]
Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. [2000.12]
Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema. [2000.06]
Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol. [2000.05]
Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion. [2000]
Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. [2000]
Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group. [2000]
No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. [1999.12]
Tacrolimus ointment improves psoriasis in a microplaque assay. [1999.07]
Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group. [1999]
A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis. [1998.12]
Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. [1998.10]
Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. [1998.10]
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. [1998.07]
[Mometasone and calcipotriol optimize the initial therapeutic effect of dithranol in chronic persistent psoriasis] [1998.04]
The calcipotriol dose-irritation relationship: 48 hour occlusive testing in healthy volunteers using Finn Chambers. [1998.02]
Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. [1998.02]
The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. [1998.01]
Combination of PUVAsol and topical calcipotriol in vitiligo. [1998]
The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. [1997.11]
Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. [1997.10]
Characterization of irritant patch test reactions to topical D vitamins and all-trans retinoic acid in comparison with sodium lauryl sulphate. Evaluation by clinical scoring and multiparametric non-invasive measuring techniques. [1997.08]
A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris. [1997.05]
Topical calcipotriol in childhood psoriasis. [1997.02]
Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. [1997.01]
Effects of calcipotriol on stratum corneum barrier function, hydration and cell renewal in humans. [1996.10]
Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study. [1996.09]
Patch test study with calcipotriol ointment in different patient groups, including psoriatic patients with and without adverse dermatitis. [1996.05]
Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study. [1995.05]
Luminal and humoral influences on human rectal epithelial cytokinetics. [1995.03]
Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. [1994.11]
A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. [1994.11]
|
